Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aratana Therapeutics Inc    PETX

ARATANA THERAPEUTICS INC

(PETX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Aratana Therapeutics : to Report Fourth Quarter and Full Year 2018 Financial Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 08:31am EDT

LEAWOOD, Kan., Feb. 12, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Tuesday, March 12, 2019 at 4:30 p.m. ET to discuss financial results from the fourth quarter and full year ended December 31, 2018.

Aratana Therapeutics logo

Interested participants and investors may access the audio webcast or use the conference call dial-in:
1 (866) 364-3820 (U.S.)
1 (855) 669-9657 (Canada)
1 (412) 902-4210 (International)

A replay of the fourth quarter and full year 2018 results teleconference will be available within several hours of the event and an audio webcast will be accessible for 90 days in the Aratana Investor Room. For a replay of the call, use the below dial-in and conference ID 10128673:

1 (877) 344-7529 (U.S.)
1 (855) 669-9658 (Canada)
1 (412) 317-0088 (International)

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. As a pioneer in pet therapeutics, Aratana's mission is to deliver safe and effective therapeutics that elevate the standard of care in veterinary medicine. We work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners. For more information, please visit www.aratana.com.

Contacts
For investor inquires:
ir@aratana.com 
(913) 353-1026

For media inquiries:
Rachel Reiff
media@aratana.com
(913) 353-1050

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-fourth-quarter-and-full-year-2018-financial-results-300794037.html

SOURCE Aratana Therapeutics, Inc.


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ARATANA THERAPEUTICS INC
03/15ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K..
AQ
03/13ARATANA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
03/12ARATANA : 4Q Earnings Snapshot
AQ
03/12ARATANA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
03/12ARATANA THERAPEUTICS : Reports Fourth Quarter and Full Year 2018 Financial Resul..
PR
02/13ARATANA THERAPEUTICS : to Participate at Upcoming Investment Conferences
PR
02/12ARATANA THERAPEUTICS : to Report Fourth Quarter and Full Year 2018 Financial Res..
PR
02/05ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Ev..
AQ
02/04ARATANA THERAPEUTICS : Appoints Rhonda Hellums Chief Financial Officer
PR
01/22ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financia..
AQ
More news